{"transactions":[{"id":4627550,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-09-28T20:08:12.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":9160,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants vest 25% on April 14, 2027 and thereafter in 36 equal monthly installments."}],"balance_after":9160,"derivative":{"exercise_price":249.84,"expiration_date":"2036-04-14","underlying":"Ordinary Shares","underlying_shares":9160},"source":{"system":"sec-edgar","filing":"0001610717-26-000423","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000423/form4.xml","form_type":"4"}},{"id":4627549,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2026-09-28T20:08:12.000Z","date":"2026-04-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9160,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to cancellation of a warrant granted on June 10, 2025, and was awarded a new warrant as part of his appointment to the board of directors of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants vest 25% on June 10, 2026 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":172.35,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":9160},"source":{"system":"sec-edgar","filing":"0001610717-26-000423","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000423/form4.xml","form_type":"4"}},{"id":681157,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T20:10:06.000Z","date":"2026-08-17","kind":"purchase","planned":true,"acquired":true,"shares":1000,"price":10.27,"value":10270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.02 to $10.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":19592,"source":{"system":"sec-edgar","filing":"0001221590-26-000025","document":"form4-08192026_040802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000025/form4-08192026_040802.xml","form_type":"4"}},{"id":683459,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-19T01:02:43.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":246.91,"value":222219.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $246.48 to $247.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2900,"source":{"system":"sec-edgar","filing":"0001610717-26-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000360/form4.xml","form_type":"4"}},{"id":683458,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-19T01:02:43.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":245.85,"value":270435.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $245.41 to $246.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001610717-26-000360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000360/form4.xml","form_type":"4"}},{"id":706643,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:10:06.000Z","date":"2026-07-15","kind":"purchase","planned":true,"acquired":true,"shares":1000,"price":10.61,"value":10610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.46 to $10.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":18592,"source":{"system":"sec-edgar","filing":"0001221590-26-000023","document":"form4-07172026_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000023/form4-07172026_040701.xml","form_type":"4"}},{"id":733752,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:55:50.000Z","date":"2026-06-15","kind":"purchase","planned":true,"acquired":true,"shares":1000,"price":10.19,"value":10190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.99 to $10.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17592,"source":{"system":"sec-edgar","filing":"0001221590-26-000021","document":"form4-06172026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000021/form4-06172026_080646.xml","form_type":"4"}},{"id":739717,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:54:12.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001221590-26-000018","document":"form4-06122026_090608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000018/form4-06122026_090608.xml","form_type":"4"}},{"id":743866,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2026-06-10T20:06:09.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":6111,"derivative":{"exercise_price":100.64,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001221590-26-000017","document":"wk-form4_1781121966.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000122159026000017/wk-form4_1781121966.xml","form_type":"4"}},{"id":743865,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:06:09.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":24424,"source":{"system":"sec-edgar","filing":"0001221590-26-000017","document":"wk-form4_1781121966.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000122159026000017/wk-form4_1781121966.xml","form_type":"4"}},{"id":744561,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":19.27,"value":19270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":43415,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744560,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":19.46,"value":68110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":42415,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744559,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":19.48,"value":116880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":38915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744558,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":19.41,"value":194100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":32915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744557,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":500,"price":19.44,"value":9720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":42915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":747702,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:15:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":7433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in equal quarterly installments over the 12 months following June 3, 2026, provided that the grant will in any case be fully vested on the date of Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":7433,"derivative":{"exercise_price":10.5,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":7433},"source":{"system":"sec-edgar","filing":"0001221590-26-000013","document":"form4-06052026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000013/form4-06052026_040601.xml","form_type":"4"}},{"id":747701,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:15:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":7142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs fully vest on the earlier of (A) June 3, 2027 and (B) the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":16592,"source":{"system":"sec-edgar","filing":"0001221590-26-000013","document":"form4-06052026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000013/form4-06052026_040601.xml","form_type":"4"}},{"id":757029,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":223.5,"value":22350.0,"ownership":{"direct":true},"balance_after":900,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":757028,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":222.3,"value":44460.0,"ownership":{"direct":true},"balance_after":800,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":757027,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:11:13.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":223.76,"value":44752.0,"ownership":{"direct":true},"balance_after":600,"source":{"system":"sec-edgar","filing":"0001610717-26-000177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/form4.xml","form_type":"4"}},{"id":760792,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-28T20:03:11.000Z","date":"2026-05-26","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":0,"derivative":{"exercise_price":84.53,"expiration_date":"2026-05-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001221590-26-000011","document":"wk-form4_1779998588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000122159026000011/wk-form4_1779998588.xml","form_type":"4"}},{"id":760791,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-28T20:03:11.000Z","date":"2026-05-26","kind":"tax_withholding","planned":true,"acquired":false,"shares":13059,"price":97.1,"value":1268028.9,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy the payment of the cost of exercise the option award previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":22782,"source":{"system":"sec-edgar","filing":"0001221590-26-000011","document":"wk-form4_1779998588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000122159026000011/wk-form4_1779998588.xml","form_type":"4"}},{"id":760790,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-28T20:03:11.000Z","date":"2026-05-26","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":84.53,"value":1267950.0,"ownership":{"direct":true},"balance_after":35841,"source":{"system":"sec-edgar","filing":"0001221590-26-000011","document":"wk-form4_1779998588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000122159026000011/wk-form4_1779998588.xml","form_type":"4"}},{"id":761735,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-27T20:05:26.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":239.3675,"value":47873.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $239.245 to $239.490 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001610717-26-000161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/form4.xml","form_type":"4"}},{"id":761734,"issuer":{"id":1628,"kind":"organization","name":"Ascendis Pharma A/S","symbol":"ASND"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-27T20:05:26.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":236.235,"value":47247.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $235.93 to $236.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001610717-26-000161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/form4.xml","form_type":"4"}},{"id":771640,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:15:07.000Z","date":"2026-05-15","kind":"purchase","planned":true,"acquired":true,"shares":1000,"price":10.58,"value":10580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.44 to $10.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":9450,"source":{"system":"sec-edgar","filing":"0001221590-26-000009","document":"form4-05192026_040503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000009/form4-05192026_040503.xml","form_type":"4"}},{"id":771928,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T11:56:51.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":20.7,"value":103500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $20.70, and the range of prices were between $20.645 and $20.72, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":43415,"source":{"system":"sec-edgar","filing":"0001221590-26-000007","document":"form4-05192026_110547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000007/form4-05192026_110547.xml","form_type":"4"}},{"id":805357,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T20:15:09.000Z","date":"2026-04-15","kind":"purchase","planned":true,"acquired":true,"shares":1000,"price":11.7,"value":11700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.56 to $11.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":8450,"source":{"system":"sec-edgar","filing":"0001221590-26-000005","document":"form4-04172026_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000005/form4-04172026_040401.xml","form_type":"4"}},{"id":845963,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T10:05:05.000Z","date":"2026-03-11","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":21.55,"value":21550.0,"ownership":{"direct":true},"balance_after":38415,"source":{"system":"sec-edgar","filing":"0001221590-26-000003","document":"form4-03122026_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000003/form4-03122026_060301.xml","form_type":"4"}},{"id":845962,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T10:05:05.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":22.12,"value":22120.0,"ownership":{"direct":true},"balance_after":37415,"source":{"system":"sec-edgar","filing":"0001221590-26-000003","document":"form4-03122026_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000003/form4-03122026_060301.xml","form_type":"4"}},{"id":848482,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T20:33:59.000Z","date":"2026-03-09","kind":"purchase","planned":true,"acquired":true,"shares":2000,"price":11.21,"value":22420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were purchased pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.98 to $11.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7450,"source":{"system":"sec-edgar","filing":"0001221590-26-000002","document":"form4-03112026_080355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000122159026000002/form4-03112026_080355.xml","form_type":"4"}},{"id":1113263,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:52:28.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016980","document":"form4-06122025_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016980/form4-06122025_080623.xml","form_type":"4"}},{"id":1114196,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2025-06-12T20:30:12.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9216,"derivative":{"exercise_price":70.07,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":9216},"source":{"system":"sec-edgar","filing":"0001628280-25-031009","document":"wk-form4_1749760200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031009/wk-form4_1749760200.xml","form_type":"4"}},{"id":1114195,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:30:12.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20841,"source":{"system":"sec-edgar","filing":"0001628280-25-031009","document":"wk-form4_1749760200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025031009/wk-form4_1749760200.xml","form_type":"4"}},{"id":1119379,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:15:05.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10500,"derivative":{"exercise_price":14.82,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-25-015971","document":"form4-06062025_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000141588925015971/form4-06062025_040601.xml","form_type":"4"}},{"id":1119378,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:15:05.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs fully vest on the earlier of (A) June 4, 2026 and (B) the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":5450,"source":{"system":"sec-edgar","filing":"0001415889-25-015971","document":"form4-06062025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000141588925015971/form4-06062025_040601.xml","form_type":"4"}},{"id":1124760,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T01:21:39.000Z","date":"2025-06-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":9.38,"value":46900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $9.38, and the range of prices were between $9.36 and $9.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":36415,"source":{"system":"sec-edgar","filing":"0001415889-25-015478","document":"form4-06042025_010636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925015478/form4-06042025_010636.xml","form_type":"4"}},{"id":1190846,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-26T20:05:21.000Z","date":"2025-03-25","kind":"purchase","planned":false,"acquired":true,"shares":7800,"price":7.78,"value":60684.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $7.78, and the range of prices were between $7.37 and $8.51, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":31415,"source":{"system":"sec-edgar","filing":"0001415889-25-009019","document":"form4-03262025_080315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925009019/form4-03262025_080315.xml","form_type":"4"}},{"id":1192186,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-25T21:18:02.000Z","date":"2025-03-24","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":8.21,"value":57470.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $8.21, and the range of prices were between $8.16 and $8.42, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":23615,"source":{"system":"sec-edgar","filing":"0001415889-25-008920","document":"form4-03252025_090358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925008920/form4-03252025_090358.xml","form_type":"4"}},{"id":1429273,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T01:07:13.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":13.944,"value":97608.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $13.944, and the range of prices were between $13.750 and $14.210. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":16615,"source":{"system":"sec-edgar","filing":"0001415889-24-021659","document":"form4-08202024_010811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021659/form4-08202024_010811.xml","form_type":"4"}},{"id":1475139,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-19T00:52:09.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 4 quarterly installments, commencing from June 13, 2024 until the one year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date."}],"balance_after":11333,"derivative":{"exercise_price":16.04,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001415889-24-017518","document":"form4-06192024_120605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924017518/form4-06192024_120605.xml","form_type":"4"}},{"id":1479854,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2024-06-14T16:17:21.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12517,"derivative":{"exercise_price":59.94,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0000879169-24-000097","document":"wk-form4_1718381833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000097/wk-form4_1718381833.xml","form_type":"4"}},{"id":1479853,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:17:21.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":2830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":18323,"source":{"system":"sec-edgar","filing":"0000879169-24-000097","document":"wk-form4_1718381833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000097/wk-form4_1718381833.xml","form_type":"4"}},{"id":1489701,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T20:11:49.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest in equal quarterly installments commencing on September 3, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":17600,"derivative":{"exercise_price":48.67,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001415889-24-015552","document":"form4-06052024_080645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221590/000141588924015552/form4-06052024_080645.xml","form_type":"4"}},{"id":1505355,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:49:33.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":13.5699,"value":27139.8,"ownership":{"direct":true},"balance_after":9615,"source":{"system":"sec-edgar","filing":"0001415889-24-014107","document":"form4-05222024_080525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924014107/form4-05222024_080525.xml","form_type":"4"}},{"id":1507559,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:09:39.000Z","date":"2024-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1202,"price":77.05,"value":92614.1,"ownership":{"direct":true},"balance_after":473792,"source":{"system":"sec-edgar","filing":"0001048477-24-000086","document":"wk-form4_1716322162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000086/wk-form4_1716322162.xml","form_type":"4"}},{"id":1519494,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-10","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":51000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1519493,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":71000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1519492,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-10","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":81.14,"value":1622800.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":474994,"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1519491,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-10","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":63.1,"value":1262000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":494994,"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1519490,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-09","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":81.62,"value":1632400.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":474994,"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1519489,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:57:27.000Z","date":"2024-05-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":63.1,"value":1262000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":494994,"source":{"system":"sec-edgar","filing":"0001048477-24-000079","document":"wk-form4_1715630235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000079/wk-form4_1715630235.xml","form_type":"4"}},{"id":1542129,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":91000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1542128,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-11","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":111000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1542127,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":91.26,"value":1825200.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":474994,"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1542126,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":63.1,"value":1262000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":494994,"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1542125,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-11","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":90.99,"value":1819800.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":474994,"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1542124,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-15T20:21:23.000Z","date":"2024-04-11","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":63.1,"value":1262000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":494994,"source":{"system":"sec-edgar","filing":"0001048477-24-000063","document":"wk-form4_1713212473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/wk-form4_1713212473.xml","form_type":"4"}},{"id":1570134,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-20T00:40:57.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":85209,"price":83.87,"value":7146478.83,"ownership":{"direct":true},"balance_after":474994,"source":{"system":"sec-edgar","filing":"0001048477-24-000038","document":"wk-form4_1710895245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000038/wk-form4_1710895245.xml","form_type":"4"}},{"id":1589772,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T22:35:37.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":86.713,"value":86713.0,"ownership":{"direct":true},"balance_after":560203,"source":{"system":"sec-edgar","filing":"0001048477-24-000032","document":"wk-form4_1709850926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000032/wk-form4_1709850926.xml","form_type":"4"}},{"id":1589771,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T22:35:37.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":85.51,"value":85510.0,"ownership":{"direct":true},"balance_after":561203,"source":{"system":"sec-edgar","filing":"0001048477-24-000032","document":"wk-form4_1709850926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000032/wk-form4_1709850926.xml","form_type":"4"}},{"id":1610631,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T22:05:21.000Z","date":"2024-02-27","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":90.35,"value":90350.0,"ownership":{"direct":true},"balance_after":562203,"source":{"system":"sec-edgar","filing":"0001048477-24-000018","document":"wk-form4_1709244306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000018/wk-form4_1709244306.xml","form_type":"4"}},{"id":1610630,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T22:05:21.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":24926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":563203,"source":{"system":"sec-edgar","filing":"0001048477-24-000018","document":"wk-form4_1709244306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000018/wk-form4_1709244306.xml","form_type":"4"}},{"id":1610629,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T22:05:21.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":35975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":538277,"source":{"system":"sec-edgar","filing":"0001048477-24-000018","document":"wk-form4_1709244306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000018/wk-form4_1709244306.xml","form_type":"4"}},{"id":1610628,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T22:05:21.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":82700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":502302,"source":{"system":"sec-edgar","filing":"0001048477-24-000018","document":"wk-form4_1709244306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000018/wk-form4_1709244306.xml","form_type":"4"}},{"id":1649903,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":131000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649902,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":146000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649901,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-09","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":88.28,"value":1324200.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":419602,"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649900,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-09","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":63.1,"value":946500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":434602,"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649899,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":89.77,"value":1346550.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":419602,"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649898,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:20:05.000Z","date":"2024-02-08","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":63.1,"value":946500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":434602,"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649897,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:20:05.000Z","date":"2024-01-18","kind":"other","planned":true,"acquired":true,"shares":40,"price":92.5975,"value":3703.9,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 40 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price. The purchase price actually paid ranged from $92.595 to $92.60. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":419602,"source":{"system":"sec-edgar","filing":"0001048477-24-000010","document":"wk-form4_1707776385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000010/wk-form4_1707776385.xml","form_type":"4"}},{"id":1649896,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T20:24:21.000Z","date":"2023-02-09","kind":"gift","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":419562,"source":{"system":"sec-edgar","filing":"0001048477-24-000008","document":"wk-form5_1707769448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000008/wk-form5_1707769448.xml","form_type":"5"}},{"id":1649895,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T20:24:21.000Z","date":"2023-02-07","kind":"gift","planned":false,"acquired":false,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":419762,"source":{"system":"sec-edgar","filing":"0001048477-24-000008","document":"wk-form5_1707769448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000008/wk-form5_1707769448.xml","form_type":"5"}},{"id":1649894,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T20:24:21.000Z","date":"2023-02-06","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":424162,"source":{"system":"sec-edgar","filing":"0001048477-24-000008","document":"wk-form5_1707769448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000008/wk-form5_1707769448.xml","form_type":"5"}},{"id":1680971,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-10","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":161000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680970,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-09","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":171000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680969,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-10","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":96.38,"value":963800.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":425162,"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680968,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-10","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":63.1,"value":631000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":435162,"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680967,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-09","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":98.19,"value":981900.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":425162,"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680966,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-09","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":63.1,"value":631000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":435162,"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1680965,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T19:40:39.000Z","date":"2024-01-08","kind":"other","planned":true,"acquired":true,"shares":50,"price":99.0518,"value":4952.59,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs."}],"balance_after":425162,"source":{"system":"sec-edgar","filing":"0001048477-24-000002","document":"wk-form4_1705002030.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000002/wk-form4_1705002030.xml","form_type":"4"}},{"id":1701295,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-12-22T22:14:23.000Z","date":"2023-12-21","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":181000,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001048477-23-000064","document":"wk-form4_1703283254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000064/wk-form4_1703283254.xml","form_type":"4"}},{"id":1701294,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-22T22:14:23.000Z","date":"2023-12-21","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":93.99,"value":939900.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":425112,"source":{"system":"sec-edgar","filing":"0001048477-23-000064","document":"wk-form4_1703283254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000064/wk-form4_1703283254.xml","form_type":"4"}},{"id":1701293,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-22T22:14:23.000Z","date":"2023-12-21","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":63.1,"value":631000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on August 7, 2023."}],"balance_after":435112,"source":{"system":"sec-edgar","filing":"0001048477-23-000064","document":"wk-form4_1703283254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000064/wk-form4_1703283254.xml","form_type":"4"}},{"id":1714957,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T00:55:13.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":2370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units granted on December 1, 2023. Price not applicable."}],"balance_after":425112,"source":{"system":"sec-edgar","filing":"0001048477-23-000057","document":"wk-form4_1702428903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000057/wk-form4_1702428903.xml","form_type":"4"}},{"id":1714956,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T00:55:13.000Z","date":"2023-10-04","kind":"other","planned":false,"acquired":true,"shares":10,"price":85.5664,"value":855.664,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's sale of shares at a price of $99.56 on April 10, 2023. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs."}],"balance_after":422742,"source":{"system":"sec-edgar","filing":"0001048477-23-000057","document":"wk-form4_1702428903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000057/wk-form4_1702428903.xml","form_type":"4"}},{"id":1745681,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-09T21:25:27.000Z","date":"2023-11-07","kind":"grant","planned":false,"acquired":true,"shares":40696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 12 quarterly installments over three years, commencing on November 7, 2023 and continuing thereafter on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date."}],"balance_after":40696,"derivative":{"exercise_price":8.91,"expiration_date":"2033-11-06","underlying":"Common Stock","underlying_shares":40696},"source":{"system":"sec-edgar","filing":"0001209191-23-054838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919123054838/doc4.xml","form_type":"4"}},{"id":1812307,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-09T23:05:03.000Z","date":"2023-08-08","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":88.29,"value":529740.0,"ownership":{"direct":true},"balance_after":422732,"source":{"system":"sec-edgar","filing":"0001048477-23-000031","document":"wk-form4_1691622294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000031/wk-form4_1691622294.xml","form_type":"4"}},{"id":1812306,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-09T23:05:03.000Z","date":"2023-08-07","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":88.1,"value":352400.0,"ownership":{"direct":true},"balance_after":428732,"source":{"system":"sec-edgar","filing":"0001048477-23-000031","document":"wk-form4_1691622294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000031/wk-form4_1691622294.xml","form_type":"4"}},{"id":1853301,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-16T20:00:13.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":11294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":11294,"derivative":{"exercise_price":61.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":11294},"source":{"system":"sec-edgar","filing":"0001209191-23-037794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037794/doc4.xml","form_type":"4"}},{"id":1853300,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:13.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan).  The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":15493,"source":{"system":"sec-edgar","filing":"0001209191-23-037794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037794/doc4.xml","form_type":"4"}},{"id":1892053,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":7370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":7370},"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1892052,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":39130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":39130},"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1892051,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":33644,"price":93.93,"value":3160180.92,"ownership":{"direct":true},"balance_after":432732,"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1892050,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6337,"price":93.93,"value":595234.41,"ownership":{"direct":true},"balance_after":466376,"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1892049,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":7370,"price":67.81,"value":499759.7,"ownership":{"direct":true},"balance_after":472713,"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1892048,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-16T21:22:29.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":39130,"price":67.81,"value":2653405.3,"ownership":{"direct":true},"balance_after":465343,"source":{"system":"sec-edgar","filing":"0001209191-23-029870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029870/doc4.xml","form_type":"4"}},{"id":1893918,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-05-15T20:58:53.000Z","date":"2023-05-11","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 17, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":39130,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-029509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029509/doc4.xml","form_type":"4"}},{"id":1893917,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-15T20:58:53.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":5561,"price":95.22,"value":529518.42,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 17, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price. The price actually received ranged from $94.94 to $95.39. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":426213,"source":{"system":"sec-edgar","filing":"0001209191-23-029509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123029509/doc4.xml","form_type":"4"}}],"next_cursor":"2023-05-15T20:58:53.000000Z,1893917"}